VMCPX
Price
$431.18
Change
+$3.86 (+0.90%)
Updated
Jun 2 closing price
Net Assets
213.76B
VSNGX
Price
$68.00
Change
+$0.31 (+0.46%)
Updated
Jun 2 closing price
Net Assets
6.01B
Interact to see
Advertisement

VMCPX vs VSNGX

Header iconVMCPX vs VSNGX Comparison
Open Charts VMCPX vs VSNGXBanner chart's image
VMCPX vs VSNGX Comparison Chart in %
View a ticker or compare two or three
VS
VMCPX vs. VSNGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMCPX is a Buy and VSNGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 214B vs. VSNGX (6.01B). VMCPX pays higher dividends than VSNGX: VMCPX (1.38) vs VSNGX (0.41). VMCPX was incepted earlier than VSNGX: VMCPX (15 years) vs VSNGX (29 years). VSNGX (0.97) is less costly to investors than VMCPX (0.02). VSNGX is a more actively managed with annual turnover of: 61.00 vs. VMCPX (16.00). VSNGX has a lower initial minimum investment than VMCPX: VSNGX (1000000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 17.07 vs. VSNGX (7.81). VMCPX return over 5 years is better than : 36.98 vs. VSNGX (10.33).
VMCPXVSNGXVMCPX / VSNGX
Total Expense Ratio0.020.842%
Annual Report Gross Expense Ratio0.020.972%
Fund Existence15 years29 years-
Gain YTD9.1926.632139%
Front LoadN/AN/A-
Min. Initial Investment100000000100000010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets214B6.01B3,561%
Annual Yield % from dividends1.380.41340%
Returns for 1 year17.077.81218%
Returns for 3 years51.7231.51164%
Returns for 5 years36.9810.33358%
Returns for 10 years159.3459.80266%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POR49.491.02
+2.10%
Portland General Electric Company
ENR18.31-0.09
-0.49%
Energizer Holdings
SCM8.96-0.10
-1.10%
STELLUS CAPITAL INVESTMENT Corp
CME250.53-7.23
-2.80%
CME Group
BRNS0.66-0.02
-3.04%
Barinthus Biotherapeutics plc